Treatment of Urinary Tract Infections with Nalidixic Acid. A Clinical Trial

Abstract
Patients (35), 2 of them males, with urinary tract infections, were treated with the new antibacterial agent nalidixic-acid. Duration of therapy varied from 5-10 days but the organism was not eradicated in 75% of all cases.

This publication has 0 references indexed in Scilit: